Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (571-580 of 831) with videos related to

Pageof 84
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <i>EGFR</i>-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent TumorsJörg Felsberg, Bettina Hentschel, Kerstin Kaulich, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
Neuro-Oncology|June 26, 2021
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumorsTobias Walbert, Rebecca A Harrison, David Schiff, et al.
Neuro-Oncology Advances|July 30, 2025
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trialJulia Furtner, Luzia Berchtold, Emilie Le Rhun, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2020
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancerAnna S Berghoff, Christoph Wippel, Angelika M Starzer, et al.
Neuro-Oncology|October 31, 2014
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastomaAnna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, et al.
Acta Neuropathologica|July 20, 2012
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-statusPierre Bady, Davide Sciuscio, Annie-Claire Diserens, et al.
Neuro-Oncology|June 28, 2021
EANO guideline on the diagnosis and management of meningiomasRoland Goldbrunner, Pantelis Stavrinou, Michael D Jenkinson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2018
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [<sup>18</sup>F]FDG: version 1.0Ian Law, Nathalie L Albert, Javier Arbizu, et al.
Oncotarget|February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcomeMichael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Pageof 84

Showing results (571-580 of 831) with videos related to

Sort By:
Pageof 84
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <i>EGFR</i>-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent TumorsJörg Felsberg, Bettina Hentschel, Kerstin Kaulich, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
Neuro-Oncology|June 26, 2021
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumorsTobias Walbert, Rebecca A Harrison, David Schiff, et al.
Neuro-Oncology Advances|July 30, 2025
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trialJulia Furtner, Luzia Berchtold, Emilie Le Rhun, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2020
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancerAnna S Berghoff, Christoph Wippel, Angelika M Starzer, et al.
Neuro-Oncology|October 31, 2014
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastomaAnna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, et al.
Acta Neuropathologica|July 20, 2012
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-statusPierre Bady, Davide Sciuscio, Annie-Claire Diserens, et al.
Neuro-Oncology|June 28, 2021
EANO guideline on the diagnosis and management of meningiomasRoland Goldbrunner, Pantelis Stavrinou, Michael D Jenkinson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2018
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [<sup>18</sup>F]FDG: version 1.0Ian Law, Nathalie L Albert, Javier Arbizu, et al.
Oncotarget|February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcomeMichael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Pageof 84